Kyowa Kirin Co., Ltd. (4151.T)

JPY 2393.0

(0.46%)

Total Liabilities Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual total liabilities in 2023 was 189.52 Billion JPY , up 7.04% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly total liabilities in 2024 Q1 was 221.91 Billion JPY , up 17.09% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported annual total liabilities of 177.05 Billion JPY in 2022, down -4.14% from previous year.
  • Kyowa Kirin Co., Ltd. reported annual total liabilities of 184.71 Billion JPY in 2021, up 79.51% from previous year.
  • Kyowa Kirin Co., Ltd. reported quarterly total liabilities of 206.71 Billion JPY for 2024 Q3, down -0.29% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported quarterly total liabilities of 221.91 Billion JPY for 2024 Q1, up 17.09% from previous quarter.

Annual Total Liabilities Chart of Kyowa Kirin Co., Ltd. (2023 - 1999)

Historical Annual Total Liabilities of Kyowa Kirin Co., Ltd. (2023 - 1999)

Year Total Liabilities Total Liabilities Growth
2023 189.52 Billion JPY 7.04%
2022 177.05 Billion JPY -4.14%
2021 184.71 Billion JPY 79.51%
2020 102.89 Billion JPY -3.12%
2019 106.2 Billion JPY 14.99%
2018 92.36 Billion JPY 0.1%
2017 92.26 Billion JPY -4.31%
2016 96.42 Billion JPY -8.96%
2015 105.9 Billion JPY -6.91%
2014 113.76 Billion JPY -8.14%
2013 123.84 Billion JPY 0.32%
2012 123.44 Billion JPY 3.87%
2011 118.85 Billion JPY -21.22%
2010 150.87 Billion JPY -2.62%
2009 154.92 Billion JPY -0.67%
2008 155.97 Billion JPY 13.58%
2007 137.32 Billion JPY 1.88%
2006 134.78 Billion JPY 6.23%
2005 126.89 Billion JPY -7.78%
2004 137.59 Billion JPY 2.17%
2003 134.66 Billion JPY -9.18%
2002 148.27 Billion JPY -31.68%
2001 217.01 Billion JPY -7.4%
2000 234.35 Billion JPY -0.24%
1999 234.91 Billion JPY 0.0%

Peer Total Liabilities Comparison of Kyowa Kirin Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Astellas Pharma Inc. 1973.61 Billion JPY 90.397%
Chugai Pharmaceutical Co., Ltd. 306.96 Billion JPY 38.259%
Ono Pharmaceutical Co., Ltd. 115.06 Billion JPY -64.712%
Santen Pharmaceutical Co., Ltd. 130.33 Billion JPY -45.418%
JCR Pharmaceuticals Co., Ltd. 45.74 Billion JPY -314.267%
Daiichi Sankyo Company, Limited 1763.11 Billion JPY 89.251%
Otsuka Holdings Co., Ltd. 924.92 Billion JPY 79.509%
Perseus Proteomics Inc. 295.46 Million JPY -64043.976%